Download
Download by
Scanning QR Code
No matches yet
Please check network settings and try again Refresh
Loading
Futu Hot Stocks
    Latest News
    History record delete
      Quotes All >
      News All >
      Help All >

      • Download app

        Download app

      +
      Congratulations
      You've successfully got advanced quotes worth 5000 HKD
      Download APP >>
      Quotes
      Detailed Quotes
      Company Overview
      Company ProfileCompany Executives
      Financial Analysis
      Main CompositionKey IndicatorsFinancial Statement
      Multi-dimentional Analyses
      Company Valuation Capital Tracking Short Selling Data
      Futubull > Quotes > COYA Coya Therapeutics > Financial Statement > Cash flow
      COYA Coya Therapeutics
      4.370
      +0.220+5.30%
      Post Mkt Price
      4.340
      -0.030-0.69%
      Income statement Balance sheet Cash flow
      YOY
      Do not show
      Hide blank lines
      (Q1)2023/03/31(FY)2022/12/31(Q4)2022/12/31(Q1)2022/03/31
      Investing cash flow
      Cash flow from continuing investing activities
      -283.76% -525K -390K
      Net PPE purchase and sale
      -- -- -- 0 -- 0 -- --
      Net other investing changes
      -- -- -- -525K -- -390K -- --
      Cash from discontinued investing activities
      Investing cash flow
      -- -- -283.76% -525K -- -390K -- --
      Financing cash flow
      Cash flow from continuing financing activities
      21,947.26% 14.25M 2,847.60% 9.36M 69.53% -104.07K -65.23K
      Net issuance payments of debt
      -- 14.25M -- 10.47M -- 0 -- 0
      Proceeds from stock option exercised by employees
      -- 0 -50.16% 158 -- 0 -- 158
      Net other financing activities
      -- -- -225.97% -1.11M 69.56% -104.07K -- -65.39K
      Cash from discontinued financing activities
      Financing cash flow
      21,947.26% 14.25M 2,847.60% 9.36M 69.53% -104.07K -- -65.23K
      Net cash flow
      Beginning cash position
      36.72% 5.93M -50.23% 4.34M 51.79% 8.65M -- 4.34M
      Current changes in cash
      606.68% 10.39M 136.38% 1.59M -99.95% -2.72M -- -2.05M
      End cash Position
      612.59% 16.32M 36.72% 5.93M 36.72% 5.93M -- 2.29M
      Free cash flow
      -94.68% -3.86M -79.19% -7.24M -118.52% -2.22M -- -1.98M
      Investing cash flow
      Cash flow from continuing investing activities
      -283.76% -525K -390K
      Net PPE purchase and sale
      -- -- -- 0 -- 0 -- --
      Net other investing changes
      -- -- -- -525K -- -390K -- --
      Cash from discontinued investing activities
      Investing cash flow
      -- -- -283.76% -525K -- -390K -- --
      Financing cash flow
      Cash flow from continuing financing activities
      21,947.26% 14.25M 2,847.60% 9.36M 69.53% -104.07K -65.23K
      Net issuance payments of debt
      -- 14.25M -- 10.47M -- 0 -- 0
      Proceeds from stock option exercised by employees
      -- 0 -50.16% 158 -- 0 -- 158
      Net other financing activities
      -- -- -225.97% -1.11M 69.56% -104.07K -- -65.39K
      Cash from discontinued financing activities
      Financing cash flow
      21,947.26% 14.25M 2,847.60% 9.36M 69.53% -104.07K -- -65.23K
      Net cash flow
      Beginning cash position
      36.72% 5.93M -50.23% 4.34M 51.79% 8.65M -- 4.34M
      Current changes in cash
      606.68% 10.39M 136.38% 1.59M -99.95% -2.72M -- -2.05M
      End cash Position
      612.59% 16.32M 36.72% 5.93M 36.72% 5.93M -- 2.29M
      Free cash flow
      -94.68% -3.86M -79.19% -7.24M -118.52% -2.22M -- -1.98M
      Currency Unit
      USDUSDUSDUSD
      Accounting Standards
      US-GAAPUS-GAAPUS-GAAPUS-GAAP
      Audit Opinions
      --Unqualified Opinion with Explanatory Notes----

      FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

      Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

      The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

      Company Overview More
      CEO： Dr. Howard Berman, PhD
      Market： NASDAQ
      Listing Date： 12/29/2022
      Futu Hot List
      USHKCN
      TradeSearchNews
      SymbolLatest price%Chg

      Loading...

      Watchlist
      Back to the Top